Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06755-5.pdf
Reference92 articles.
1. Jones SE (2008) Metastatic breast cancer: the treatment challenge. Clin Breast Cancer 8:224–233
2. Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky R (2014) Optimizing dosing of oncology drugs. Clin Pharmacol Ther 96:572–579
3. Ratain MJ, Tannock IF, Lichter AS (2021) Dose optimization of sotorasib: is the US Food and Drug Administration sending a message? J Clin Oncol 39:3423–3426
4. Kuchuk I, Bouganim N, Beusterien K, Grinspan J, Vandermeer L, Gertler S, Dent S, Song X, Segal R, Mazzarello S (2013) Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Res Treat 142:101–107
5. Wood R, Mitra D, de Courcy J, Iyer S (2017) Patient-reported quality of life and treatment satisfaction in patients with HR+/HER2–advanced/metastatic breast cancer. Clin Ther 39:1719–1728
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs;Clinical Pharmacology & Therapeutics;2024-07-29
2. The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life;JCO Oncology Practice;2024-07
3. Dose Optimization of Targeted Therapies for Oncologic Indications;Cancers;2024-06-09
4. Leben mit metastasiertem Mammakarzinom;Die Onkologie;2024-04-04
5. The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma;Clinical Trials;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3